Member akshay
Member-
akshay posted an update in the group
7 weeks agoPharma News 7 weeks agoPharmaceutical Companies Expand AI Use to Accelerate Drug Discovery
Major pharmaceutical companies are increasingly adopting artificial intelligence to speed up drug discovery and reduce research costs. Industry leaders report that AI-driven platforms are helping identify potential drug candidates faster, optimize clinical trial design, and…
-
akshay posted an update in the group
8 weeks agoPharma News 8 weeks agoGlobal Pharma Industry Eyes Faster Patient Access with EU Regulatory Overhaul
The European Union has reached a landmark agreement to reform drug regulations, aiming to speed up patient access to medicines across the bloc. The new framework revises data and market exclusivity rules, supports antibiotic innovation, and strengthens supply…
-
akshay posted an update in the group
2 months agoPharma News 2 months agoNew Cancer Drug License — Hope for Patients in India
As a practising doctor in India, I’m encouraged by the latest development: Dr Reddy’s Laboratories has signed an exclusive licensing agreement with Australia-based Immutep to market a promising new cancer drug — a move that could expand therapeutic options for patients across the…
-
akshay posted an update in the group
2 months agoPharma News 2 months agoIndia’s First Home-grown Antibiotic Is Here
As a doctor, I’m genuinely excited about a recent milestone in Indian medicine — the launch of Nafithromycin, the first antibiotic discovered, developed and clinically validated entirely in India.
This antibiotic — marketed as Miqnaf — promises a short, once-daily, three-day treatment for…
-
akshay posted an update in the group
2 months agoPharma News 2 months agoFDA Approves Novel Drug for Rare Fat-Metabolism Disorder
This week, the U.S. Food and Drug Administration (FDA) approved Plozasiran (brand name: Redemplo) — a new siRNA therapy for Familial Chylomicronemia Syndrome (FCS), a rare genetic disorder that causes dangerously high triglyceride levels.
✅ What This Means from a Doctor’s Perspective
-
For…
-
-
akshay posted an update in the group
2 months agoPharma News 2 months ago🩺 A Doctor’s Note on India’s Pharma Trade Scrutiny
I’m deeply concerned—but also cautiously hopeful—about the recent anti‑dumping probe India has launched into imports of Ethambutol Hydrochloride, a key API used in TB drugs.
From a medical standpoint:
-
Access to TB medicines is non-negotiable—we rely on affordable, consistent supply to treat…
-
-
akshay posted an update in the group
2 months agoPharma News 2 months agoCDSCO Releases Updated Draft Guidelines for AI-Enabled Medical Device Software
As a physician who increasingly relies on digital health tools, I find India’s latest move hugely significant: the CDSCO has published a draft guidance document for medical-device software (SaMD and SiMD), including AI/ML-based applications.
What this means for us at…
-
akshay posted an update in the group
2 months agoPharma News 2 months agoIndia Expands CDSCO Workforce With 419 New Drug Inspectors
The Health Ministry has officially approved 419 new Drug Inspector posts under CDSCO to strengthen drug-quality surveillance across the country. This is one of the largest regulatory workforce expansions in years.As a doctor, here’s why this matters for all of us in healthcare:
-
Stronger…
-
-
akshay posted an update in the group
2 months agoPharma News 2 months agoIndian Drugmaker Glenmark Pharmaceuticals Reports 72% Profit Surge — What It Means for Clinicians
As a physician, I pay attention not only to new medicines but also to how the pharma industry is evolving — because stronger companies often mean better supply, better innovation and improved access for my patients. Glenmark Pharmaceuticals…
-
akshay posted an update in the group
2 months agoPharma News 2 months agoIndia Launches ‘i-Passport’ for MedTech Startups
As a practicing physician, I believe meaningful change in healthcare doesn’t just come from new drugs — it comes from smarter systems too. Recently, the Andhra Pradesh MedTech Zone (AMTZ) in Visakhapatnam introduced the “i-Passport”, a streamlined gateway for med-tech and health-tech…
-
akshay posted an update in the group
2 months agoPharma News 2 months agoWegovy Price Cut of Up to 37% in India
Novo Nordisk has cut the Indian price of its weight-loss drug Wegovy (semaglutide) by up to 37%.
Why this matters:-
Affordability is a major barrier in real-world practice; price reductions can increase adoption and allow more patients access.
-
However, it also raises expectations: if we use the drug…
-
-
akshay posted an update in the group
2 months agoPharma News 2 months ago⚠️ Regulation Tightens on Pharma Manufacturing
As a physician, patient safety is always front and centre—and recent regulatory action in India demands our attention. The Central Drugs Standard Control Organisation (CDSCO) has mandated that all pharmaceutical manufacturers must meet international standards by January 1, 2026—following a tragic…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoNew Drug & Device Milestones Highlight Shift to Innovation
Two recent announcements stand out for us in clinical practice:
-
Finerenone (brand name Kerendia) has just received expanded approval in India for treating adult patients with heart‐failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF). This opens up treatment for a…
-
-
akshay posted an update in the group
3 months agoPharma News 3 months agoIndia OKs Self-Certification for 1,000+ Medical Devices — A Doctor’s Take
As a clinician, I welcome any move that speeds access to safe, affordable equipment—but only if safety keeps pace. India will now allow self-certification for over a thousand low- to moderate-risk medical devices (think stethoscopes, wheelchairs, swabs, scissors). The aim…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoFrom the Clinic: Why the Recent Pharma-Quality Crisis Hits Us Doctors at the Bedside
As a physician, the recent developments in India’s pharmaceutical industry have been deeply unsettling. Authorities have issued a hard-hitting advisory after discovering that multiple manufacturing facilities failed to test every batch of raw materials or…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoWhy Pharma and Physicians Must Connect Beyond the Trial
In my practice, the moment a new drug emerges from trials into the real world, everything changes. While randomized controlled trials give us foundational safety and efficacy, it’s real-world evidence (RWE) that reveals how treatments perform in everyday settings—across comorbidities,…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoVirtual Meetings: The New Bridge Between Pharma and Physicians
As a doctor, I’ve seen a major transformation in how the pharmaceutical industry connects with healthcare professionals — and it’s all thanks to virtual meetings. What used to be long in-person sessions or conferences has now evolved into focused, efficient digital…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoHow Artificial Intelligence Is Transforming Communication Across Pharma
As a doctor, I’ve always believed that the foundation of good healthcare lies in communication — between clinicians, patients, researchers, and the pharmaceutical industry. Yet, for decades, that communication has often been fragmented and slow. Today, Artificial…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoCollaborative Platforms: The New Prescription for Healthcare Innovation
As a doctor, I’ve witnessed how digital collaboration platforms are transforming the healthcare industry. Platforms like HealthSocial allow doctors, researchers, and pharma professionals to exchange ideas instantly — breaking silos that once slowed progress.
Whether it’s…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoCough Syrup Tragedy Exposes Fragility in India’s Drug Safety Oversight
As a clinician deeply invested in both patient safety and pharmaceutical integrity, recent events surrounding contaminated cough syrups in India have shaken me to the core. This isn’t just “another pharma scandal” — it’s a stark warning that regulatory gaps, quality lapses,…
- Load More
